Literature DB >> 30688680

Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.

Jun Seok Park1, Soo Yeun Park1, Hye Jin Kim1, Seung Hyun Cho1,2, Sang Gyu Kwak3, Gyu-Seog Choi1.   

Abstract

BACKGROUND: To date only few data have been available relating to the oncologic safety of intersphincteric resection in such advanced tumors.
OBJECTIVE: This study aimed to elucidate the oncologic outcomes and clinical factors affecting the long-term survival of patients who underwent preoperative chemoradiotherapy followed by intersphincteric resection for locally advanced rectal cancers.
DESIGN: This was a retrospective analysis of prospectively collected departmental data. SETTINGS: The study was conducted at a department of colorectal surgery in a tertiary care teaching hospital between January 2009 and September 2015. PATIENTS: A cohort of 147 consecutive patients with low rectal cancer undergoing intersphincteric resection after preoperative chemoradiotherapy was included. MAIN OUTCOME MEASURES: Kaplan-Meier analyses were used to evaluate the 3-year disease-free survival and local recurrence rates. Logistic regression analyses were used to analyze the influence of tumor response and other prognostic factors on survival outcomes.
RESULTS: Median follow-up was 34 months (range, 8-94 mo). The estimated overall 3-year disease-free survival and local recurrence rates were 64.9% and 11.7%. Circumferential resection margin involvement and pathologic T stage (ypT stage) were significant predictors of cancer relapse. The 3-year disease-free survival was 47.4% for patients with ypT3 tumors compared with 82.0% for those with ypT0-2 tumors (p = 0.001). The 3-year disease-free survival was 36.5% for patients with involved circumferential resection margins compared with 69.7% for those with a noninvolved circumferential resection margin (p = 0.003). On multivariate analysis, ypT stage, ymrT stage, and circumferential resection margin status were associated with worse disease-free survival. Clinical T-stage and pathologic distal margin status were not independent factors affecting oncologic outcomes. LIMITATIONS: This study is limited with respect to its retrospective design.
CONCLUSIONS: In these patients with locally advanced low rectal cancers, intersphincteric resection after preoperative chemoradiotherapy was associated with acceptable oncologic outcomes. See Video Abstract at http://links.lww.com/DCR/A941.

Entities:  

Mesh:

Year:  2019        PMID: 30688680     DOI: 10.1097/DCR.0000000000001321

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  7 in total

Review 1.  State of the Art - Rectal Cancer Surgery.

Authors:  Andreas Bogner; Johanna Kirchberg; Jürgen Weitz; Johannes Fritzmann
Journal:  Visc Med       Date:  2019-06-27

2.  Initial experience of preoperative short-course radiotherapy followed by oxaliplatin-based consolidation chemotherapy for locally advanced rectal cancer.

Authors:  Jun Seok Park; Min Kyu Kang; Seung Ho Song; Gyu-Seog Choi; Soo Yeun Park; Hye Jin Kim; Jong Gwang Kim; Byung Woog Kang; Jin Ho Baek; Dong Won Baek; Jae-Chul Kim; Shin-Hyung Park; Seung Hyun Cho; An Na Seo
Journal:  Int J Colorectal Dis       Date:  2021-02-06       Impact factor: 2.571

Review 3.  Reconsideration of the Safety of Laparoscopic Rectal Surgery for Cancer.

Authors:  Gyung Mo Son; Bong-Hyeon Kye; Min Ki Kim; Jun-Gi Kim
Journal:  Ann Coloproctol       Date:  2019-10-31

4.  Efficacy and safety of short duration radiotherapy combined with chemotherapy for advanced rectal cancer.

Authors:  Shu-Quan Gao; Ying-Chun Zhang; Chao Zhang; Sheng-Jie Wang; Wei Ren; Na Yuan; Jun-Ye Wen
Journal:  World J Clin Cases       Date:  2021-03-06       Impact factor: 1.337

Review 5.  Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes.

Authors:  Guglielmo Niccolò Piozzi; Seon Hahn Kim
Journal:  Ann Coloproctol       Date:  2021-11-17

6.  Management of Low Rectal Cancer Complicating Ulcerative Colitis: Proposal of a Treatment Algorithm.

Authors:  Bruno Sensi; Giulia Bagaglini; Vittoria Bellato; Daniele Cerbo; Andrea Martina Guida; Jim Khan; Yves Panis; Luca Savino; Leandro Siragusa; Giuseppe S Sica
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

Review 7.  Ultimate Functional Preservation With Intersphincteric Resection for Rectal Cancer.

Authors:  Maxime Collard; Jérémie H Lefevre
Journal:  Front Oncol       Date:  2020-03-05       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.